Hoefnagel MHN - Search Results

1

Corrigendum to "Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines" [Vaccine 39(18) (2021) 2506-2516].

Stalpers CAL, Retmana IA, Pennings JLA, Vandebriel RJ, Hendriksen CFM, Akkermans AM, Hoefnagel MHN. Stalpers CAL, et al. Among authors: hoefnagel mhn. Vaccine. 2022 May 20;40(23):3272-3273. doi: 10.1016/j.vaccine.2022.04.047. Epub 2022 Apr 22. Vaccine. 2022. PMID: 35469695 Free article. No abstract available.

2

Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity.

Hoefnagel MH, Vermeulen JP, Scheper RJ, Vandebriel RJ. Hoefnagel MH, et al. Vaccine. 2011 Jul 18;29(32):5114-21. doi: 10.1016/j.vaccine.2011.05.050. Epub 2011 May 30. Vaccine. 2011. PMID: 21624423

3

Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines.

Stalpers CAL, Retmana IA, Pennings JLA, Vandebriel RJ, Hendriksen CFM, Akkermans AM, Hoefnagel MHN. Stalpers CAL, et al. Among authors: hoefnagel mhn. Vaccine. 2021 Apr 28;39(18):2506-2516. doi: 10.1016/j.vaccine.2021.03.078. Epub 2021 Apr 3. Vaccine. 2021. PMID: 33824038 Free article.

4

Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines.

van den Biggelaar RHGA, Hoefnagel MHN, Vandebriel RJ, Sloots A, Hendriksen CFM, van Eden W, Rutten VPMG, Jansen CA. van den Biggelaar RHGA, et al. Among authors: hoefnagel mhn. Expert Rev Vaccines. 2021 Oct;20(10):1221-1233. doi: 10.1080/14760584.2021.1977628. Epub 2021 Sep 22. Expert Rev Vaccines. 2021. PMID: 34550041 Review.

5

Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation.

Vandebriel RJ, Stalpers CAL, Vermeulen JP, Remkes M, Schmelter M, Broere F, Hoefnagel MHN. Vandebriel RJ, et al. Among authors: hoefnagel mhn. Vaccine. 2022 Sep 9;40(38):5601-5607. doi: 10.1016/j.vaccine.2022.08.022. Epub 2022 Aug 20. Vaccine. 2022. PMID: 35999078 Free article.

6

Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines.

van Walstijn C, Verweij S, Care R, Rigsby P, Clapper EB, Markey K, Vandebriel RJ, Stickings P, Hoefnagel MHN. van Walstijn C, et al. Among authors: hoefnagel mhn. Vaccine. 2023 Aug 31;41(38):5603-5613. doi: 10.1016/j.vaccine.2023.07.054. Epub 2023 Jul 30. Vaccine. 2023. PMID: 37527955 Free article.

7

Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over in vivo release testing of vaccines.

Hoefnagel MHN, Stickings P, Smith D, Jungbäck C, Van Molle W, Tesolin L. Hoefnagel MHN, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):369-377. doi: 10.1080/14760584.2023.2198601. Expert Rev Vaccines. 2023. PMID: 37010241 Free article.

8

Estimation of manufacturing development costs of cell-based therapies: a feasibility study.

Ten Ham RMT, Nievaart JC, Hoekman J, Cooper RS, Frederix GWJ, Leufkens HGM, Klungel OH, Ovelgönne H, Hoefnagel MHN, Turner ML, Mountford JC. Ten Ham RMT, et al. Among authors: hoefnagel mhn. Cytotherapy. 2021 Aug;23(8):730-739. doi: 10.1016/j.jcyt.2020.12.014. Epub 2021 Feb 13. Cytotherapy. 2021. PMID: 33593688 Free article.

9

Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.

de Wolf ACMT, Herberts CA, Hoefnagel MHN. de Wolf ACMT, et al. Among authors: hoefnagel mhn. Front Med (Lausanne). 2020 Apr 2;7:91. doi: 10.3389/fmed.2020.00091. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32300597 Free PMC article.

10

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.

Ten Ham RMT, Hövels AM, Hoekman J, Frederix GWJ, Leufkens HGM, Klungel OH, Jedema I, Veld SAJ, Nikolic T, Van Pel M, Zwaginga JJ, Lin F, de Goede AL, Schreibelt G, Budde S, de Vries IJM, Wilkie GM, Dolstra H, Ovelgönne H, Meij P, Mountford JC, Turner ML, Hoefnagel MHN. Ten Ham RMT, et al. Among authors: hoefnagel mhn. Cytotherapy. 2020 Jul;22(7):388-397. doi: 10.1016/j.jcyt.2020.03.432. Epub 2020 May 12. Cytotherapy. 2020. PMID: 32414635 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page